•
Sep 30, 2024

iTeos Therapeutics Q3 2024 Earnings Report

Total Revenue
$0
EPS
-$1.05
Previous year: -$0.9
+16.7%
Gross Profit
-$302K
Previous year: -$224K
+34.8%
Cash and Equivalents
$489M
Previous year: $599M
-18.4%
Free Cash Flow
-$37.4M
Previous year: -$34.6M
+8.1%
Total Assets
$723M
Previous year: $678M
+6.7%

iTeos Therapeutics

iTeos Therapeutics